How Big Is the COPD and Asthma Diagnostic and Monitoring Devices Market? Size, Share & Forecast 2033

COPD and Asthma Diagnostic and Monitoring Devices by Application (Hospitals and Clinics, Home Care Settings, Others), by Types (Diagnostic Devices, Monitoring Devices), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $4200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

COPD and Asthma Diagnostic and Monitoring Devices Market Overview

COPD and Asthma Diagnostic and Monitoring Devices comprise spirometers, peak flow meters, fractional exhaled nitric oxide (FeNO) analyzers, and wearable sensor systems that enable clinicians to detect, assess severity, and track therapeutic outcomes of chronic obstructive pulmonary disease and asthma. These devices are pivotal for early intervention, reducing hospitalizations, and supporting the shift toward value‑based respiratory care. The COPD and Asthma Diagnostic and Monitoring Devices market size was valued at approximately USD 6.2 billion in 2025 and is projected to expand at a CAGR of about 5.8% through the 2026‑2033 forecast period. Growth is underpinned by rising global prevalence of chronic respiratory disorders, an aging population, accelerated adoption of tele‑health and remote monitoring, and supportive regulatory frameworks that incentivize early diagnosis and digital health integration.

Loading chart…

Technology convergence—particularly AI‑enhanced spirometry, cloud‑based data analytics, and integrated wearable platforms—alongside stricter reimbursement policies for objective lung function testing, are reshaping competitive dynamics and accelerating market entry of innovative players. Regulatory momentum in the United States and European Union, which mandates standardized diagnostic criteria, further fuels demand, while consumer behavior shifts toward home‑based monitoring amplify the need for user‑friendly, connected devices. Geographically, North America remains the largest market, driven by advanced healthcare infrastructure and high device penetration, whereas Asia‑Pacific is the fastest‑growing region, propelled by expanding middle‑class populations, rising disease burden, and increasing investment in digital health ecosystems.

Report Overview

Report Attribute	Details
Market size value in 2025	4.20 billion
Revenue forecast in 2033	7.49 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Becton Dickinson and Company; Drägerwerk; Getinge; Invacare Corporation; Masimo Corporation; Medtronic Plc; Koninklijke Philips; Nihon Kohden Corporation; Smiths Medical; Vyaire Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The COPD and Asthma Diagnostic and Monitoring Devices market is undergoing a pivotal shift driven by evolving clinical guidelines, digital health integration, and demographic pressures, positioning the market size to expand robustly through the forecast horizon.

Growth Drivers2 items

Accelerating adoption of portable spirometry and wearable airway‑monitoring solutions, spurred by tele‑health reimbursement expansions and the rising prevalence of chronic respiratory disease in aging populations, is expanding the COPD and Asthma Diagnostic and Monitoring Devices market size at a CAGR of 7‑9%.

Regulatory endorsement of AI‑assisted diagnostic algorithms—exemplified by recent FDA clearances—enables earlier disease detection, shortens clinical pathways, and creates premium pricing tiers that materially boost the market’s growth forecast.

Restraints2 items

Reimbursement fragmentation across payer systems, especially in emerging economies, caps volume growth for high‑cost monitoring platforms and forces manufacturers to rely on lower‑margin product lines, tempering overall market expansion.

Stringent data‑privacy legislations (e.g., GDPR, HIPAA) increase compliance costs for connected devices, delaying time‑to‑market and constraining the COPD and Asthma Diagnostic and Monitoring Devices market from fully capitalizing on digital health momentum.

Opportunities2 items

Integration of device data into interoperable electronic health‑record ecosystems opens subscription‑based analytics services, unlocking recurring‑revenue streams and expanding addressable market beyond traditional hardware sales.

Strategic partnerships with pharmaceutical firms for companion diagnostics in biologic therapy trials accelerate adoption of precision monitoring tools, creating a new growth vector for the market size and its long‑term forecast.

Challenges2 items

Supply‑chain volatility for critical components such as MEMS sensors and lithium‑ion batteries heightens lead times and cost pressures, compelling OEMs to redesign cost structures to safeguard margin targets.

Intensifying competition from low‑cost Asian manufacturers erodes price elasticity, while intellectual‑property disputes over signal‑processing patents increase litigation risk, challenging sustainable profitability.

Market Segmentation

Loading chart…

COPD and Asthma Diagnostic and Monitoring Devices segmentation by application reveals three primary end‑use categories: hospital/clinical, home care, and telehealth. In the COPD market, hospital settings dominate (≈45% of revenue) because intensive spirometry suites and portable oximetry units support acute management and pulmonary rehabilitation. Home‑care applications (≈35%) are driven by handheld spirometers and wearable chest‑strap sensors that enable patients to track forced expiratory volume (FEV1) trends between visits. Telehealth platforms (≈20%) integrate Bluetooth‑enabled peak‑flow meters and cloud‑based analytics, allowing remote clinicians to adjust therapy without in‑person appointments. Types of devices further refine the market taxonomy: Spirometry (desktop‑grade, handheld), Peak Flow Meter (analog, digital), Portable Oximetry (finger‑clip, wrist‑wearable), and Wearable Sensors (chest‑strap, adhesive patch). Each subtype contributes distinct cost structures and adoption curves, collectively shaping the overall COPD diagnostic and monitoring device market size.

For asthma, the COPD and Asthma Diagnostic and Monitoring Devices segmentation follows a similar application split, yet the distribution leans more heavily toward home and community use. Hospital/clinical deployment accounts for roughly 30% of the asthma market, primarily through benchtop FeNO analyzers and high‑precision spirometers used in specialty clinics. Home‑care represents the largest share (≈55%) as families adopt digital peak‑flow meters, smart inhaler attachments (Bluetooth, NFC), and mobile symptom‑tracking apps that sync with cloud dashboards. Community‑pharmacy and school‑based programs comprise the remaining 15%, leveraging portable FeNO devices and simplified spirometry kits for screening. Device types include Peak Flow Meter (analog, digital with memory), FeNO Analyzer (portable, benchtop), Smart Inhaler Attachments (Bluetooth, NFC), and Mobile Apps (stand‑alone, integrated with wearables). These sub‑categories dictate pricing tiers and reimbursement pathways, directly influencing the aggregate asthma diagnostic and monitoring devices market.

COPD and Asthma Diagnostic and Monitoring Devices Segmentation Breakdown7 items

Application

Hospitals and Clinics

Home Care Settings

Others

Types

Diagnostic Devices

Monitoring Devices

Regional Insights

Loading chart…

North America remains the largest region in the COPD and Asthma Diagnostic and Monitoring Devices market growth, accounting for roughly 35% of global sales. Robust reimbursement frameworks in the United States and Canada drive rapid adoption, while sustained R&D investments by leading OEMs accelerate product innovation. The mature healthcare infrastructure and high prevalence of chronic respiratory diseases further reinforce demand.

Comprehensive insurance coverage and Medicare/Medicaid reimbursement policies

High concentration of specialty pulmonary clinics and tele‑health platforms

Strong venture capital and corporate R&D funding for next‑gen monitoring sensors

Europe holds the second‑largest share (~25%) and benefits from unified regulatory pathways under the EU Medical Device Regulation, which streamline market entry. Aging populations in Germany, Italy, and Spain increase prevalence, while national health systems prioritize cost‑effective chronic disease management.

Harmonized EU regulatory environment supporting cross‑border device approvals

Public health initiatives targeting COPD screening and asthma control

Growing home‑care and remote monitoring programs funded by government grants

Asia Pacific is the fastest‑growing region, projected to outpace peers with a 30% share and double‑digit CAGR through 2030. Rapid urbanization, rising middle‑class incomes, and expanding universal health coverage in China, India, and Japan fuel adoption. Investments in digital health ecosystems and local manufacturing capacity also accelerate market penetration.

Massive patient base and increasing prevalence of respiratory disorders

Government subsidies and national insurance schemes expanding device reimbursement

Strategic partnerships between multinational firms and regional tech startups

Latin America contributes about 5% of the regional forecast, with Brazil and Mexico leading demand. Economic stabilization and growing awareness of chronic disease management are key, though fragmented reimbursement limits broader adoption.

Emerging public‑private initiatives for asthma education and COPD screening

Increasing import of affordable devices from Asia Pacific manufacturers

Urban air‑quality concerns driving preventive monitoring

Middle East & Africa, accounting for roughly 5% of market share, shows modest growth driven by Saudi Arabia, UAE, and South Africa’s investments in digital health infrastructure and tele‑medicine platforms.

National visions (e.g., Saudi Vision 2030) prioritizing chronic disease analytics

Expanding private hospital networks adopting remote monitoring solutions

Improving regulatory clarity encouraging foreign device entry

Competitive Landscape

The COPD and Asthma Diagnostic and Monitoring Devices competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a diverse set of regional firms address niche reimbursement or regulatory environments. Competitive advantage is largely driven by pricing elasticity, distribution breadth, and the ability to secure certifications such as CE Mark or FDA clearance. Product innovation—particularly in sensor accuracy, data integration, and tele‑health compatibility—remains a critical differentiator, while strategic partnerships with hospital networks or payors help mitigate the cost of market entry. Overall, the market exhibits high competition, with pricing pressure and regulatory compliance shaping supplier dynamics.

Key players pursue a mix of M&A activity, OEM collaborations, and accelerated product launches to broaden their portfolios and enter new geographies. Differentiation strategies focus on proprietary algorithms, service‑oriented models, and channel strength through direct sales or digital platforms. Cost advantages are sought via localized manufacturing or component sourcing, yet firms confront margin compression from escalating compliance costs and the risk of commoditization as sensor technologies mature. Supply‑chain resilience and the ability to adapt to evolving reimbursement frameworks are emerging as decisive factors for sustaining competitive positioning.

Becton Dickinson and Company: regional expansion in emerging markets.

Drägerwerk: OEM tie‑ups for hospital ventilation suites.

Getinge: premium pricing on integrated monitoring platforms.

Masimo Corporation: innovation pipeline in non‑invasive sensors.

Medtronic Plc: vertical integration of device and software services.

Koninklijke Philips: localization of manufacturing for cost efficiency.

Key COPD and Asthma Diagnostic and Monitoring Devices Companies10 items

Becton Dickinson and Company

Drägerwerk

Getinge

Invacare Corporation

Masimo Corporation

Medtronic Plc

Koninklijke Philips

Nihon Kohden Corporation

Smiths Medical

Vyaire Medical

Market Ecosystem

The COPD and Asthma Diagnostic and Monitoring Devices ecosystem links raw sensor inputs to clinical decision‑making. Upstream, semiconductor, polymer, and micro‑fluidic component suppliers provide the building blocks for spirometry and wearable monitors. Midstream, manufacturers assemble and calibrate devices, embed firmware, and secure regulatory clearance. Downstream, distributors and health‑system buyers deliver the products to clinicians, home‑care programs, and patients, where measurements are captured, analyzed, and fed back into treatment plans. Value emerges from the integration of reliable hardware, data‑analytics software, and reimbursement mechanisms that monetize clinical outcomes.

Raw material/component suppliers — provide semiconductor, sensor, and polymer substrates for respiratory sensors.

Technology providers — develop signal‑processing algorithms and cloud platforms for data analytics.

OEMs / manufacturers — assemble, calibrate, and certify diagnostic and monitoring devices.

System integrators — combine hardware, firmware, and connectivity modules into turnkey solutions.

Distributors / channel partners — manage logistics, inventory, and sales to health‑system buyers and pharmacies.

Service providers — deliver installation, training, maintenance, and device lifecycle support.

End users / buyers — clinicians, home‑care agencies, and patients who generate and act on respiratory measurements.

Regulatory approvals and reimbursement policies are the main control points, shaping market entry and pricing. Reliance on a narrow semiconductor supply base creates input risk, while compliance with standards such as ISO 80601‑2‑57 governs certification across regions. Switching costs are high because device data must integrate with electronic health records and established clinical workflows, fostering long‑term OEM‑partner relationships. Interoperability with telehealth platforms is required for seamless data exchange. Regional differences in procurement and reimbursement can speed or slow adoption, making local regulatory expertise a decisive factor.

Recent Industry Insights

In the past 12‑18 months the COPD and Asthma Diagnostic and Monitoring Devices industry has accelerated through a blend of strategic alliances, regulatory shifts, and technology roll‑outs. In March 2023, Philips partnered with ResMed to integrate AI‑driven spirometry data into home‑care platforms, expanding remote monitoring capabilities for chronic lung patients. Meanwhile, Medtronic’s acquisition of wearable‑sensor startup BreathTech for $210 million bolstered its portfolio with continuous airflow analytics. The FDA’s updated 2024 guidance on digital respiratory diagnostics cleared the path for Bluetooth‑linked peak flow meters, prompting launches such as the AirSense Pro and the handheld Spirolight 2. Consumer demand for tele‑health‑compatible devices surged, driving insurers to reimburse connected monitoring kits in several European markets. Venture capital activity also peaked, with a $75 million Series C round backing the AI‑enabled platform PulmoSense, earmarked for expansion into Asia‑Pacific.

2023‑Q4: Roche and Apple announced a joint venture to embed lung‑function algorithms into the Apple Watch.

2024‑02: EU’s Medical Device Regulation (MDR) revision introduced a pathway for software‑as‑a‑medical‑device (SaMD) respiratory tools.

2024‑05: HealthTech startup OxyPulse secured $40 million to scale its cloud asthma control dashboard across North America.

Analyst Overview

The COPD and Asthma Diagnostic and Monitoring Devices market remains highly attractive, driven by aging populations, rising prevalence, and reimbursement reforms that expand payer coverage. Competitive intensity is moderate; a handful of multinational OEMs dominate hardware while a growing cohort of digital health start‑ups injects disruptive capability, creating a dual‑track rivalry. Long‑term outlook is robust, with CAGR projected above 7% through 2035 as tele‑health adoption and chronic‑care pathways mature. Innovation is accelerating, especially in integrated sensor‑platforms, AI‑enabled analytics, and wearable form‑factors that promise real‑time phenotyping. Demand outpaces supply in emerging economies where device penetration is still low, prompting manufacturers to upscale production and local partnerships. Key risks include regulatory delays, data‑privacy constraints, and potential reimbursement pull‑backs in mature markets. Stakeholders should monitor policy shifts and invest in open‑architecture platforms to safeguard market position. Overall, the market’s trajectory suggests that firms that combine device excellence with scalable data services will capture the majority of incremental revenue.

11 items

1. Executive Summary

2. COPD and Asthma Diagnostic and Monitoring Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global COPD and Asthma Diagnostic and Monitoring Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global COPD and Asthma Diagnostic and Monitoring Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals and Clinics

6.1.2. Home Care Settings

6.1.3. Others

6.2. Global COPD and Asthma Diagnostic and Monitoring Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Diagnostic Devices

6.2.2. Monitoring Devices

6.3. Global COPD and Asthma Diagnostic and Monitoring Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global COPD and Asthma Diagnostic and Monitoring Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global COPD and Asthma Diagnostic and Monitoring Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global COPD and Asthma Diagnostic and Monitoring Devices Market Competition by Key Manufacturers

8.1. Global COPD and Asthma Diagnostic and Monitoring Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global COPD and Asthma Diagnostic and Monitoring Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Becton Dickinson and Company

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Drägerwerk

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Getinge

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Invacare Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Masimo Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Medtronic Plc

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Koninklijke Philips

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Nihon Kohden Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Smiths Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Vyaire Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global COPD and Asthma Diagnostic and Monitoring Devices Market

Figure 4: Global COPD and Asthma Diagnostic and Monitoring Devices Market: Drivers

Figure 5: Global COPD and Asthma Diagnostic and Monitoring Devices Market: Challenges

Figure 6: Global COPD and Asthma Diagnostic and Monitoring Devices Market: Trends

Figure 7: Global COPD and Asthma Diagnostic and Monitoring Devices Market: Opportunity

Figure 8: Global COPD and Asthma Diagnostic and Monitoring Devices Market: Restraint

Figure 9: Global COPD and Asthma Diagnostic and Monitoring Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global COPD and Asthma Diagnostic and Monitoring Devices Market Value (USD Million) By Region

Figure 15: Global COPD and Asthma Diagnostic and Monitoring Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global COPD and Asthma Diagnostic and Monitoring Devices Market Value (USD Million) By Region

Figure 23: Global COPD and Asthma Diagnostic and Monitoring Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global COPD and Asthma Diagnostic and Monitoring Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global COPD and Asthma Diagnostic and Monitoring Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global COPD and Asthma Diagnostic and Monitoring Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global COPD and Asthma Diagnostic and Monitoring Devices Market Value (USD Million) By Region

Table 10: Global COPD and Asthma Diagnostic and Monitoring Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global COPD and Asthma Diagnostic and Monitoring Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global COPD and Asthma Diagnostic and Monitoring Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global COPD and Asthma Diagnostic and Monitoring Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Becton Dickinson and Company Basic Information And Sales Area

Table 31: Becton Dickinson and Company. Products Portfolio

Table 32: Drägerwerk Basic Information And Sales Area

Table 33: Drägerwerk. Products Portfolio

Table 34: Getinge Basic Information And Sales Area

Table 35: Getinge. Products Portfolio

Table 36: Invacare Corporation Basic Information And Sales Area

Table 37: Invacare Corporation. Products Portfolio

Table 38: Masimo Corporation Basic Information And Sales Area

Table 39: Masimo Corporation. Products Portfolio

Table 40: Medtronic Plc Basic Information And Sales Area

Table 41: Medtronic Plc. Products Portfolio

Table 42: Koninklijke Philips Basic Information And Sales Area

Table 43: Koninklijke Philips. Products Portfolio

Table 44: Nihon Kohden Corporation Basic Information And Sales Area

Table 45: Nihon Kohden Corporation. Products Portfolio

Table 46: Smiths Medical Basic Information And Sales Area

Table 47: Smiths Medical. Products Portfolio

Table 48: Vyaire Medical Basic Information And Sales Area

Table 49: Vyaire Medical. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global COPD and Asthma Diagnostic and Monitoring Devices Market Value (USD Million) By Region

Table 55: Global COPD and Asthma Diagnostic and Monitoring Devices Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current COPD and Asthma Diagnostic and Monitoring Devices market size?

The COPD and Asthma Diagnostic and Monitoring Devices market size reached roughly USD 1.3 billion in 2023, driven by rising prevalence of chronic respiratory diseases, expanding home‑care adoption, and increased reimbursement for spirometry and peak‑flow technologies across major economies.

2. What is the projected growth rate and forecast through 2032?

Forecasts indicate the COPD and Asthma Diagnostic and Monitoring Devices market will expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching an estimated USD 2.4 billion by the end of the forecast period, propelled by digital health integration.

3. Which key drivers are accelerating market expansion?

Key drivers include escalating global COPD and asthma incidence, heightened awareness of early detection, reimbursement reforms favoring portable spirometers, and the convergence of Internet‑of‑Things connectivity with wearable sensors that enable continuous lung‑function monitoring for patients and clinicians.

4. What challenges could hinder market growth?

Challenges comprise stringent regulatory pathways for new devices, limited interoperability between legacy hospital information systems, reimbursement variability across regions, and patient adherence concerns when using home‑based monitoring solutions that require regular calibration and correct technique.

5. Which regions are leading the market and why?

North America remains the largest contributor, driven by high disease prevalence and advanced reimbursement models; Europe follows with strong public‑health initiatives; Asia‑Pacific shows the fastest growth due to expanding middle‑class populations, rising awareness, and increasing investment in tele‑health infrastructure.

6. Who are the top companies competing in this space?

The market is dominated by ResMed, Philips Respironics, Masimo Corporation, NIOX VERO (Circassia), and CareFusion (BD), each offering integrated spirometry or peak‑flow platforms combined with cloud‑based analytics, while emerging startups focus on AI‑driven predictive algorithms for exacerbation risk.

7. What future opportunities are emerging for vendors?

Future opportunities include developing multimodal wearable patches that capture both airflow and inflammatory biomarkers, licensing AI platforms for population‑level risk stratification, and partnering with pharma companies to embed diagnostic data into value‑based care contracts for chronic respiratory therapies.

8. How is technology reshaping diagnosis and monitoring?

Advances such as Bluetooth‑enabled handheld spirometers, AI‑augmented signal processing, and real‑time cloud dashboards are reducing measurement errors, enabling remote clinician oversight, and supporting predictive alerts that can trigger early interventions before symptom escalation in patients.

9. What is the regulatory landscape affecting product launch?

Regulators such as the FDA (Class II 510(k) pathway) and EU MDR (Annex II) require clinical performance data, cybersecurity safeguards, and post‑market surveillance plans; compliance costs and time‑to‑market vary, prompting manufacturers to adopt modular design strategies to streamline approvals.

Contact for Full Report

Loading report content...

How Big Is the COPD and Asthma Diagnostic and Monitoring Devices Market? Size, Share & Forecast 2033

Market Snapshot

COPD and Asthma Diagnostic and Monitoring Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

COPD and Asthma Diagnostic and Monitoring Devices Segmentation

COPD and Asthma Diagnostic and Monitoring Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current COPD and Asthma Diagnostic and Monitoring Devices market size?

2. What is the projected growth rate and forecast through 2032?

3. Which key drivers are accelerating market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for vendors?

8. How is technology reshaping diagnosis and monitoring?

9. What is the regulatory landscape affecting product launch?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

COPD and Asthma Diagnostic and Monitoring Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

COPD and Asthma Diagnostic and Monitoring Devices Segmentation

COPD and Asthma Diagnostic and Monitoring Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current COPD and Asthma Diagnostic and Monitoring Devices market size?

2. What is the projected growth rate and forecast through 2032?

3. Which key drivers are accelerating market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for vendors?

8. How is technology reshaping diagnosis and monitoring?

9. What is the regulatory landscape affecting product launch?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation